The hepatitis B surface antibody test (HBsAb) detects proteins that are made by the immune system (antibodies) in response to thehepatitis B virus (HBV). The test is used to find out if you areimmuneto the virus after natural exposure or vaccination. You have to give a blood sample for ...
In a study of 39 HBsAg-negative cases cell-mediated immunity to HBsAg was observed in 24 (62%), suggesting a high frequency of previous infection with the hepatitis-B virus. Hepatitis-B surface antibody was detectable by radioimmunoassay in six patients, in all of whom complexes of HBsAg ...
乙肝表面抗体阳性、核心抗体阳性(Hepatitis B surface antibody is positive, core antibody is positive ) Hepatitis B surface antibody positive, hepatitis B core antibody positive Hepatitis B surface antibody is a protective antibody of human body, which can protect the body from HBV infection. Hepatitis...
(indicating immunity due to previous infection rather than vaccine) have hadHBVreactivation up to 2 years afterimmunosuppressionwith BRMs.95,96In patients takingrituximabor TNF-α antagonists, the highest risk for reactivation is found among those with the lowest levels ofhepatitis B surface antibody(...
Prevalence of anti hepatitis B surface antibody among children in Ahvaz, Iran, five years after vaccination. Jundishapur J Microbiol. 2011; 4 (1):e2592.Shamsizadeh A, Makvandi M, Shoshtari G. Prevalence of anti hepatitis B surface antibody among children in Ahvaz, Iran, five years after ...
Hepatitis B surface antigen (HBsAg) indicates either acute or chronicHBVinfection. People with positiveHBsAgare infectious and can transmit the virus to others. The IgM subclass of antibody to thehepatitis B core antigen(IgM anti-HBc) indicates acute infection while total IgG anti-HBc is a nonspe...
Step 1: Hepatitis B Surface Antigen (HBsAg) Positive: Go to Step 2 Negative: May still representHepatitis Binactive carrier state Step 2: Differentiate Chronic Infection vsImmunity Hepatitis B Core Antibody Hepatitis B Surface Antibody (immune) ...
Coexistence of hepatitis B surface antigen (HBsAg) and hepatitis B surface antibody (anti-HBs) has been observed in some chronic hepatitis B (CHB) patients
and formation of hepatitis B surface antibody (anti-HBs), allowing patients to achieve durable immunity with REP 9 AC and its modified form [94,95]. In a study of 12 HBeAg-positive CHB patients, the NAP HBsAg release inhibitor REP2139-Ca was given for 20–38 weeks, with response defined...
Hepatitis-B-surface-antigen-containing liposomes enhance humoral and cell-mediated immunity to the antigen [proceedings EK Manesis,CH Cameron,G Gregoriadis - 《Biochemical Society Transactions》 被引量: 0发表: 1979年 Vaccine adjuvant systems containing monophosphoryl lipid A and QS21 induce strong ...